XOMA (XOMA Ltd.)
All Pro Portfolios with XOMA

People owning XOMA also tend to own:: APABACCCFCCSCOCSXCVS

All Do-It-Yourself Portfolios with XOMA
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:edpettersen

Date:08 16 08

new drug

Not yet rated
Rate now:

By:barrons2

Date:08 02 08

Buy - Price $1.95 on July 9
by Pacific Growth Equities

XOMA's pipeline includes both proprietary products and collaborative programs at various stages of preclinical and clinical development primarily directed toward treating cancer and immune disorders. We predict breakeven and full-year profitability in 2011, with about $142 million in revenues. Longer-term, we also believe XOMA 052 [a potent monoclonal antibody targeting Interleukin-1 beta in patients with Type-2 diabetes] has blockbuster potential...Near-term catalysts include initiation of multiple Phase II trials. Market cap: $274 million.

Not yet rated
Rate now:

By:mapollack

Date:03 18 08

Small Biotech with great pipline of drugs under development. Price is down.

Not yet rated
Rate now:

Why I Hate This Stock

By:Paul LaCombe

Date:08 01 08

Another lesson in biotech. Lesson not to listen to the gossip and let the data speak for itself.

Not yet rated
Rate now:

By:Lorod

Date:07 08 08

I should have sold .

Not yet rated
Rate now:

By:podney

Date:03 14 08

GOING NO WHERE

Not yet rated
Rate now:
Add Your Comments  
Stock XOMA
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
what happened to DSCO?
07.02.09 | 11:45 AM From author Disco Duck
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. hgsi lupus drug. results on jul...
07.03.09 | 23:42 PM Asked by 1surfer2

A. the data seems really positive ... I
just read through BioMedReports and
thought it was impressive - the largest
lupus trial ever.

today 's lists
TheStreet.com TV Videos

These are some of the stocks mentioned today on TheStreet.com TV. Click the URL below each stock to watch the videos. more

TSC Ratings Downgrades

These stocks were downgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more

Analyst Upgrades

Analyst Upgrades for July 1, 2009. Read more here. more